LEXINGTON, Mass.--([ BUSINESS WIRE ])--AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG) today announced that William Heiden, AMAGas chief executive officer, will participate in two investor conferences in September. The sessions will both be conducted in a question and answer format and will include a company overview and a review of the companyas growth opportunities.
The sessions will take place as follows:
- September 5, at 1:55 p.m. ET a" Bairdas 2012 Healthcare Conference in New York City; and
- September 10, at 11:45 a.m. ET a" Morgan Stanley Global Healthcare Conference in New York City.
A live webcast of each session will be accessible through the Investor section of the companyas website at [ www.amagpharma.com ]. Following the conferences, the webcasts will be archived on the AMAG Pharmaceuticals, Inc. website for approximately two weeks.
About AMAG Pharmaceuticals, Inc.
AMAG Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on the development and commercialization of a therapeutic iron compound to treat iron deficiency anemia. For additional company information, please visit [ www.amagpharma.com ].